IL-22BP/LNP Compound
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-22BP/LNP Compound, covering 2025-12-29 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity [Phase 1]